A double-blind study of duloxetine in the treatment of depression
Zhao Xing
Abstract
Zhao Xing
Abstract
Objective To evaluate the efficacy and safety of duloxetine in the treatment of depression. Method 68 patients with depression were randomly divided into study group(duloxetine)and control group(fluxetine),and treated for 6 weeks.Efficacy and side effects were assessed with HAMD,HAMA,CGI-SI,and AE respectively before and after treatment.Results The efficacy was similar for the two drugs.The efficacious rate was 85.3% and the adverse events rate was 41.2% for duloxetine.No significant difference was found in the adverse events between the two groups.Conclusion Duloxetine is an effective drug for depression,with good tolerance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the efficacy and safety of duloxetine in the treatment of depression. Method 68 patients with depression were randomly divided into study group(duloxetine)and control group(fluxetine),and treated for 6 weeks.Efficacy and side effects were assessed with HAMD,HAMA,CGI-SI,and AE respectively before and after treatment.Results The efficacy was similar for the two drugs.The efficacious rate was 85.3% and the adverse events rate was 41.2% for duloxetine.No significant difference was found in the adverse events between the two groups.Conclusion Duloxetine is an effective drug for depression,with good tolerance.
Key concepts: Duloxetine, Medicine, Hamd, Depression (economics), Adverse effect, Internal medicine, Clinical efficacy, Duloxetine Hydrochloride